Seattle Genetics

SGEN

SGEN
Seattle Genetics Stock Quote
$87.60 $1.66 1.9%
BATS BZX Real Time Price as of October 18, 2019, 9:55 a.m. EDT View Interactive SGEN Charts

A biotechnology company, which develops monoclonal antibody-based therapies for the treatment of cancer and autoimmune diseases.

News & Analysis: Seattle Genetics

The Fool has written over 200 articles on Seattle Genetics.

All

Market Moves

Earnings











Interactive Chart